Related Experiment Video

Updated: Jun 16, 2026

Surgical Correction for Pediatric Epiblepharon and Trichiasis
03:59

Surgical Correction for Pediatric Epiblepharon and Trichiasis

Published on: July 8, 2025

[What's new in pediatric dermatology?]

J Mazereeuw-Hautier1

  • 1Service de Dermatologie, CHU Purpan, Toulouse, France. mazereeuw-hautier.j@chu-toulouse.fr

Annales De Dermatologie Et De Venereologie
|January 30, 2010
PubMed

Insights

This 2009 review highlights advancements in pediatric dermatology, detailing new findings on atopic dermatitis, vascular anomalies, congenital nevi, warts, and genodermatoses. It covers pathophysiology, clinical features, and therapeutic approaches for various skin conditions.

Area of Science:

  • Pediatric Dermatology
  • Dermatopathology
  • Clinical Research

Context:

  • The year 2009 saw significant advancements in understanding and treating pediatric skin conditions.
  • Existing literature was expanded with new research across multiple dermatological subspecialties.
  • This review synthesizes key findings from the 2009 literature.

Purpose:

  • To provide a comprehensive overview of the principal themes and new findings in pediatric dermatology for 2009.
  • To highlight advancements in pathophysiology, clinical features, and therapeutic strategies.
  • To consolidate recent research on specific conditions including atopic dermatitis, vascular anomalies, and genodermatoses.

Summary:

  • New insights into atopic dermatitis include potential triggers like breastfeeding, probiotics, and Staphylococcus aureus, alongside tacrolimus therapy.
  • Research on vascular anomalies, particularly hemangiomas, focused on evolution and propranolol efficacy.
  • Studies on genodermatoses (e.g., neurofibromatosis type I, epidermolysis bullosa) revealed novel molecular, clinical, and quality-of-life data.
  • Updates were also provided on congenital nevi, warts, Lyell syndrome, Kawasaki disease, vitiligo, psoriasis, and alopecia areata.

Impact:

  • Informs clinicians and researchers about the latest developments in pediatric skin disease management.
  • Identifies emerging trends and therapeutic targets in dermatology.
  • Facilitates evidence-based practice by summarizing critical 2009 research findings.

More Related Videos

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...